In the Spotlight

Celebrating AANHPI Heritage Month: A Conversation with Suresh Ambudkar, Ph.D.

Suresh V. Ambudkar, Ph.D., is a Senior Investigator and the Deputy Chief of the Laboratory of Cell Biology. For this Asian American, Native Hawaiian, and Pacific Islander Heritage Month Q&A, he answers some questions about his academic, research and personal journey immigrating from India to the United States.

Celebrating AANHPI Heritage Month: A Conversation with Fatima Karzai, M.D.

Fatima Karzai, M.D., Associate Research Physician and Clinical Director in the Genitourinary Malignancies Branch, is a clinical researcher at CCR. She is originally from Afghanistan. For this Asian American, Native Hawaiian, Pacific Islander Heritage Month Q&A, she discussed her research interests and how her background as an Afghan American woman influences her work today.

New Milestones publication now available

Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 14 of our top scientific advances from the past year. These discoveries include basic research to understand cancer cells, promising advances in immunotherapy for solid tumors, precision oncology for selecting the best treatment for a patient and new insights into the role of the tumor microenvironment and the microbiota in cancer treatment. Other major advances include new technology development achieved through interdisciplinary teamwork, health disparities research relating to prostate cancer and studies that led to several Food and Drug Administration approvals.

Following the fellowship experience with CCR fellow Martha Teke, M.D.

Martha Teke, M.D., is a research fellow in the Surgical Oncology and Cancer Immunotherapy Research Fellowship Program. In this Q&A, she shares her experience as a clinical fellow at CCR and what impact she hopes to leave in the world of science.

Following the fellowship experience with CCR fellow Bailey Johnson

Bailey Johnson is a postbaccalaureate fellow in the Laboratory of Cell Biology. For this Black History Month Q&A, we asked her about her research journey, personal goals and advice for the next generation of students of color.

A conversation with Troy A. McEachron, Ph.D.

Troy A. McEachron, Ph.D., Investigator in the Pediatric Oncology Branch, studies osteosarcoma, the most common type of bone cancer in children and young adults. In a new Q&A, he discusses the intriguing differences between the tumor microenvironments of primary and metastatic osteosarcomas as well as his personal goal for increasing the participation of underrepresented populations in clinical research.

A conversation with CCR immunotherapy experts

June is Immunotherapy Awareness Month. We asked members of the Surgery Branch about their work with immunotherapy as they continue to make important advances in this growing field.

New Milestones publication now available

Every year, the Center for Cancer Research makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features some of our top scientific advances in the past year at CCR. These discoveries include two new FDA-approved therapies, insights into how to design RNA-targeted therapeutics and new ways to predict treatment outcomes in immunotherapy. Other major advances include the development of new computational tools – for identifying viruses in cancer genomes and to elucidate the consequences of DNA damage – and novel diagnostic tools – one to detect liver cancer, another to precisely detect prostate cancer.

Sarcoma Awareness Month

To recognize Sarcoma Awareness Month this July, we are highlighting our researchers who are advancing research discovery in this field. Learn more...

A Conversation with Christina Annunziata, M.D., Ph.D.

Christina Annunziata, M.D., Ph.D., is an Investigator in the Women’s Malignancies Branch at the Center for Cancer Research. She has spent most of her career studying the molecular underpinnings of ovarian cancer with the goal of discovering novel treatments. In our Q&A, Dr. Annunziata discusses her personal and professional milestones as well as new directions for her research.

Breadcrumb